Differential amygdala response during facial recognition in patients with schizophrenia: An fMRI study

Schizophrenia Research

Volumn 57, Issue 1, 2002, Pages 87-95

  Kosaka, H ^a   Omori, M ^a   Murata, T ^a   Iidaka, T ^b   Yamada, H ^a   Okada, T ^c   Takahashi, T ^a   Sadato, N ^c   Itoh, H ^a   Yonekura, Y ^a   Wada, Y ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Amygdala; Emotion; Face; fMRI; Schizophrenia; SPM

Indexed keywords

ACCURACY; ADULT; AMYGDALOID NUCLEUS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; ELECTROENCEPHALOGRAM; EMOTION; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECOGNITION; SCHIZOPHRENIA; STATISTICAL ANALYSIS; TASK PERFORMANCE;

ADOLESCENT; ADULT; AMYGDALA; FACE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA;

EID: 0036723102     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00324-3     Document Type: Article

References (39)

1. Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala
2. Recognition of facial emotion in nine individuals with bilateral amygdala damage
3. A role for somatosensory cortices in the visual recognition of emotion as revealed by three-dimensional lesion mapping
4. The contribution of the amygdala to normal and abnormal emotional states
5. Intact recognition of vocal expression of fear following bilateral lesions of the human amygdala
6. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging
7. Dissociable neural responses to facial expressions of sadness and anger
8. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage
9. Information processing and attention dysfunctions in schizophrenia
10. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients
11. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures
12. PET and MRI of the thalamus in never-medicated patients with schizophrenia
13. The amygdala: Vigilance and emotion
14. An MRI-based probablistic atlas of neuroanatomy
15. Facial discrimination and emotional recognition in schizophrenia and affective disorders
16. Gaze discrimination is unimpaired in schizophrenia
17. How many subjects constitute a study?
18. Modulating emotional response: Effects of a neocortical network on the limbic system
19. Facial emotion discrimination: III. Behavioral findings in schizophrenia
20. Emotion circuits in the brain
21. Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus
22. A neuromodulatory role for the human amygdala in processing emotional facial expressions
23. Deficits in facial-affect recognition and schizophrenia
24. Schizophrenia - An emotional hypersensitivity of the right cerebral hemisphere
25. The assessment and analysis of handedness: The Edinburgh inventory
26. The brief psychiatric rating scale
27. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics
28. Cerebral blood flow changes associated with attribution of emotional valence to pleasant, unpleasant, and neutral visual stimuli in a PET study of normal subjects
29. Ziskined-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder
30. A differential neural response to threatening and non-threatening negative facial expressions in paranoid and non-paranoid schizophrenics
31. Gaze discrimination in patients with schizophrenia: Preliminary report
32. Mood effects on limbic blood flow correlate with emotional self-rating: A PET study with oxygen-15 labeled water
33. Differential amygdala activation in schizophrenia during sadness
34. Recognition and identification of facial stimuli by schizophrenics and patients with affective disorders
35. Functional magnetic resonance imaging at 1.5 T: Activation pattern in schizophrenic patients receiving neuroleptic medication
36. A self-rating depression scale